Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases

Abstract

The invention provides the use of a cyclodextrin compound for the manufacturing of a medicament for the treatment or prevention of bronchial inflammatory diseases, particularly for asthma.

1 - 10 . (canceled) 
     
     
         11 . A method for the treatment of COPD (chronic obstructive pulmonary disease) in a host mammal in need of such treatment, consisting essentially of the step of administering an effective amount of cyclodextrin compound to the mammal, wherein the cyclodextrin compound is selected from the group consisting of:
 β-cyclodextrin, hydroxypropyl-βcyclodextrin, sulfolbutylether-βcyclodextrin, random methylated-βcyclodextrin, dimethyl-βcyclodextrin, trimethyl-βcyclodextrin, hydroxypropyl βcyclodextrin, hydroxybutyl βcyclodextrin, glucosyl-βcyclodextrin, maltosyl-βcyclodextrin, 2-O-methyl-βcyclodextrin or a combination thereof and their pharmaceutically acceptable salts.   
     
     
         12 . A method for treatment of COPD comprising the administration to a patient in need of such treatment of an effective dose of cyclodextrin compound alone.